The day before their game against the Titans, the Ravens added Lamar Jackson to their injury report.

0

The day before their game against the Titans, the Ravens added Lamar Jackson to their injury report.

Lamar Jackson appeared to be in good spirits during his Friday press conference, but the Baltimore Ravens’ latest move suggests otherwise.

The Ravens added Jackson to their injury report with an illness on Saturday afternoon.

He’ll play against the Chicago Bears on Sunday, but he’s listed as questionable.

Jackson was sick this week and missed two practices.

He said he had a cold when he returned to the team’s facility on Friday.

He made a joke about his immune system as well.

“I don’t get sick very often,” Jackson said.

“When I was a kid, I used to take my Flintstone vitamins.”

“I should have a good immune system.”

Despite Jackson’s claim that he’s “feeling great,” the fact that he’s officially questionable raises some concerns about his health.

Tyler Huntley would be the starting quarterback if the Ravens rule out Jackson for Sunday’s game.

On Wednesday and Thursday, he received first-team reps in practice.

The Ravens’ offense would clearly suffer if Jackson were to be sidelined for a week.

This season, the former MVP has 2,447 passing yards, 639 rushing yards, and 16 total touchdowns.

On Sunday morning, the Ravens will know more about Jackson’s status.

The Bears-Ravens game will begin at 1 p.m.

CBS, 8:00 p.m. ET

The Ravens add Lamar Jackson to their injury report the day before their game against the Titans.

Bears are a type of animal that lives in

charset=”utf-8″ wpcc-script async src=”https://platform.twitter.com/widgets.js” wpcc-script async src=”https://platform.twitter.com/widgets.js” wpcc-script async src=”https

Ravens Add Lamar Jackson To Injury Report Day Before Game vs. Bears

Ravens Add Lamar Jackson To Injury Report Day Before Game vs. Bears

Ravens Add Lamar Jackson To Injury Report Day Before Game vs. Bears

Ravens Add Lamar Jackson To Injury Report Day Before Game vs. Bears

Comments are closed.